BioRestorative Therapies annual return on equity
2021
2022
2023
2024
2025
BioRestorative Therapies Return on Equity (ROE) Growth & History (BRTX)
BioRestorative Therapies's return on equity was −320.47% for fiscal 2025.
View full BioRestorative Therapies company overviewBioRestorative Therapies annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −320.47% | −223.58 pp |
| 2024 | 2024-12-31 | −96.89% | +5.78 pp |
| 2023 | 2023-12-31 | −102.66% | +22.83 pp |
| 2022 | 2022-12-31 | −125.49% | +812.02 pp |
| 2021 | 2021-12-31 | −937.51% | — |
BioRestorative Therapies quarterly return on equity
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −127.39% | −54.62 pp |
| Q4 2025 | 2025-12-31 | −250.23% | −232.57 pp |
| Q3 2025 | 2025-09-30 | −86.16% | −75.67 pp |
| Q2 2025 | 2025-06-30 | −48.34% | −16.50 pp |
| Q1 2025 | 2025-03-31 | −72.77% | −54.63 pp |
| Q4 2024 | 2024-12-31 | −17.67% | +4.53 pp |
| Q3 2024 | 2024-09-30 | −10.50% | −81.64 pp |
| Q2 2024 | 2024-06-30 | −31.84% | +93.61 pp |
| Q1 2024 | 2024-03-31 | −18.14% | +67.51 pp |
| Q4 2023 | 2023-12-31 | −22.19% | −2.64 pp |
| Q3 2023 | 2023-09-30 | 71.14% | +101.74 pp |
| Q2 2023 | 2023-06-30 | −125.46% | −141.46 pp |
| Q1 2023 | 2023-03-31 | −85.66% | −32.60 pp |
| Q4 2022 | 2022-12-31 | −19.55% | +671.68 pp |
| Q3 2022 | 2022-09-30 | −30.61% | — |
| Q2 2022 | 2022-06-30 | 16.00% | — |
| Q1 2022 | 2022-03-31 | −53.05% | — |
| Q4 2021 | 2021-12-31 | −691.23% | — |
BioRestorative Therapies return on equity trends
Between the periods ended 2021-12-31 and 2025-12-31, BioRestorative Therapies's return on equity increased from −937.51% to −320.47%, a change of +617.04 percentage points. The latest reported quarter, Q1 2026, shows −127.39%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioRestorative Therapies source filings ↗